2025-02-01 2026-01-31 2026-01-31 false 12145573 Meridian Research Ltd 80100Private security activities iso4217:GBP xbrli:pure 121455732025-02-01 121455732026-01-31 121455732025-02-01 2026-01-31 12145573bus:SmallEntities2025-02-01 2026-01-31 12145573bus:AuditExempt-NoAccountantsReport2025-02-01 2026-01-31 12145573bus:AbridgedAccounts2025-02-01 2026-01-31 12145573core:WithinOneYear2026-01-31 12145573core:AfterOneYear2026-01-31 12145573core:WithinOneYear2025-02-01 2026-01-31 12145573core:AfterOneYear2025-02-01 2026-01-31 12145573core:CurrentFinancialInstruments2026-01-31 12145573core:Non-currentFinancialInstruments2026-01-31 12145573core:CurrentFinancialInstruments2025-02-01 2026-01-31 12145573core:Non-currentFinancialInstruments2025-02-01 2026-01-31 12145573core:LandBuildings2025-02-01 2026-01-31 12145573core:FurnitureFittings2025-02-01 2026-01-31 12145573core:OfficeEquipment2025-02-01 2026-01-31 12145573core:Vehicles2025-02-01 2026-01-31 12145573core:PlantMachinery2025-02-01 2026-01-31 12145573core:OtherPropertyPlantEquipment2025-02-01 2026-01-31 12145573core:LandBuildings2026-01-31 12145573core:PlantMachinery2026-01-31 12145573core:Vehicles2026-01-31 12145573core:FurnitureFittings2026-01-31 12145573core:OfficeEquipment2026-01-31 12145573core:OtherPropertyPlantEquipment2026-01-31 12145573core:Right-of-useAssets2025-02-01 2026-01-31 12145573core:Right-of-useAssets2026-01-31 12145573core:Goodwill2025-02-01 2026-01-31 12145573core:PatentsTrademarksLicencesConcessionsSimilar2025-02-01 2026-01-31 12145573core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-02-01 2026-01-31 12145573core:OtherResidualIntangibleAssets2025-02-01 2026-01-31 12145573core:Goodwill2026-01-31 12145573core:DevelopmentCostsCapitalisedDevelopmentExpenditure2026-01-31 12145573core:PatentsTrademarksLicencesConcessionsSimilar2026-01-31 12145573core:OtherResidualIntangibleAssets2026-01-31 12145573dpl:CostSales2025-02-01 2026-01-31 12145573dpl:AdministrativeExpenses2025-02-01 2026-01-31 12145573dpl:DistributionCosts2025-02-01 2026-01-3112145573core:ShareCapital2026-01-31 12145573core:SharePremium2026-01-31 12145573core:RevaluationReserve2026-01-31 12145573core:OtherReservesSubtotal2026-01-31 12145573core:ShareCapitalPreferenceShares2026-01-31 12145573core:CapitalRedemptionReserve2026-01-31 12145573core:OtherCapitalReserve2026-01-31 12145573core:RetainedEarningsAccumulatedLosses2026-01-3112145573core:ShareCapital2025-02-01 2026-01-31 12145573core:SharePremium2025-02-01 2026-01-31 12145573core:RevaluationReserve2025-02-01 2026-01-31 12145573core:OtherReservesSubtotal2025-02-01 2026-01-31 12145573core:RetainedEarningsAccumulatedLosses2025-02-01 2026-01-311214557312025-02-01 2026-01-31 1214557322025-02-01 2026-01-3112145573core:ShareCapital12025-02-01 2026-01-31 12145573core:ShareCapital22025-02-01 2026-01-3112145573core:SharePremium12025-02-01 2026-01-31 12145573core:SharePremium22025-02-01 2026-01-3112145573core:RevaluationReserve12025-02-01 2026-01-31 12145573core:RevaluationReserve22025-02-01 2026-01-3112145573core:RetainedEarningsAccumulatedLosses12025-02-01 2026-01-31 12145573core:RetainedEarningsAccumulatedLosses22025-02-01 2026-01-311214557312025-02-01 2026-01-3112145573core:Non-currentFinancialInstrumentscore:CostValuation2025-02-01 12145573core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2026-01-31 12145573core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2026-01-3112145573core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2026-01-31 12145573core:Non-currentFinancialInstrumentscore:TransfersIntoOrOutInvestmentsIncreaseDecreaseInInvestments2026-01-31 12145573core:Non-currentFinancialInstrumentscore:CostValuation2026-01-3112145573core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2025-02-01 12145573core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2026-01-31 12145573core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2026-01-31 12145573core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2026-01-31 12145573core:Non-currentFinancialInstrumentscore:FurtherSpecificIncreaseDecreaseInProvisionsForImpairmentInvestments1ComponentCorrespondingTotal2026-01-31 12145573core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2026-01-31 12145573core:Non-currentFinancialInstrumentscore:ProvisionsForImpairmentInvestments2026-01-3112145573core:Non-currentFinancialInstruments2026-01-31 12145573core:Non-currentFinancialInstruments2025-01-31121455732024-02-01 121455732025-01-31 121455732024-02-01 2025-01-31 12145573core:WithinOneYear2025-01-31 12145573core:AfterOneYear2025-01-31 12145573core:CurrentFinancialInstruments2025-01-31 12145573core:Non-currentFinancialInstruments2025-01-31 12145573core:LandBuildings2025-01-31 12145573core:PlantMachinery2025-01-31 12145573core:Vehicles2025-01-31 12145573core:FurnitureFittings2025-01-31 12145573core:OfficeEquipment2025-01-31 12145573core:OtherPropertyPlantEquipment2025-01-31 12145573core:Right-of-useAssets2025-01-31 12145573core:Goodwill2025-01-31 12145573core:DevelopmentCostsCapitalisedDevelopmentExpenditure2025-01-31 12145573core:PatentsTrademarksLicencesConcessionsSimilar2025-01-31 12145573core:OtherResidualIntangibleAssets2025-01-31 12145573dpl:AdministrativeExpenses2024-02-01 2025-01-3112145573core:ShareCapital2025-01-31 12145573core:SharePremium2025-01-31 12145573core:RevaluationReserve2025-01-31 12145573core:OtherReservesSubtotal2025-01-31 12145573core:ShareCapitalPreferenceShares2025-01-31 12145573core:CapitalRedemptionReserve2025-01-31 12145573core:OtherCapitalReserve2025-01-31 12145573core:RetainedEarningsAccumulatedLosses2025-01-3112145573core:RetainedEarningsAccumulatedLosses2024-02-01 12145573core:ShareCapital2024-02-01 12145573core:SharePremium2024-02-01 12145573core:RevaluationReserve2024-02-01 12145573core:ShareCapital2024-02-01 2025-01-31 12145573core:SharePremium2024-02-01 2025-01-31 12145573core:RevaluationReserve2024-02-01 2025-01-31 12145573core:OtherReservesSubtotal2024-02-01 2025-01-31 12145573core:RetainedEarningsAccumulatedLosses2024-02-01 2025-01-311214557312024-02-01 2025-01-31 1214557322024-02-01 2025-01-3112145573core:ShareCapital12024-02-01 2025-01-31 12145573core:ShareCapital22024-02-01 2025-01-3112145573core:SharePremium12024-02-01 2025-01-31 12145573core:SharePremium22024-02-01 2025-01-3112145573core:RevaluationReserve12024-02-01 2025-01-31 12145573core:RevaluationReserve22024-02-01 2025-01-3112145573core:RetainedEarningsAccumulatedLosses12024-02-01 2025-01-31 12145573core:RetainedEarningsAccumulatedLosses22024-02-01 2025-01-3112145573bus:Director12025-02-01 2026-01-3112145573bus:PrivateLimitedCompanyLtd2025-02-01 2026-01-31
Meridian Research Ltd
Unaudited Financial Statements
for the year ended 31 January 2026
Company registration number 12145573
(England and Wales)

Company Information

For the year ended 31 January 2026
Director Mr B Sparkes

Registered office 22 Wessex Park
Bancombe Business Estate
Somerton
TA11 6SB

Registered number 12145573

Accountant Somerset Accountancy Services Limited
22 Wessex Park
Bancombe Business Estate
SOMERTON
Somerset
TA11 6SB

Balance Sheet

As at 31 January 2026
Notes
2026
2025
£
£
£
£
Fixed assets
Tangible assets
7,453
8,527
7,453
8,527
Current assets
Debtors
5
302,338
230,726
Investments
6
555,315
509,481
Cash at bank and in hand
44,537
125,853
902,190
866,060
Creditors
Amounts falling due within one year
7
(58,010)
(71,576)
(58,010)
(71,576)
Net current assets (liabilities)
844,180
794,484
Total assets less current liabilities
851,633
803,011
Provisions for liabilities
9
(1,821)
(2,131)
Net assets (liabilities)
849,812
800,880
Capital and reserves
Called up share capital
10
1
1
Profit and loss account
849,811
800,879
Total equity
849,812
800,880

The company is a private company limited by shares and registered in England and Wales. It was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
The financial statements have been prepared in accordance with the special provisions applicable to companies subject to the small companies regime.
The directors have chosen to not file a copy of the company's profit and loss account under section 444 (5A) of the Companies Act 2006.
The members have agreed to the preparation of abridged accounts for this accounting period in accordance with section 444 (2A) of the Companies Act 2006.

The financial statements were approved and authorised for issue by the director on 16 October 2026 and are signed on its behalf by:

Mr B Sparkes
Mr B Sparkes
Director

Company registration number 12145573

Notes to the Financial Statements

For the year ended 31 January 2026

1. Statutory information

The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The financial statements are presented in sterling and this is the functional currency of the company.

2. Accounting policies

2.1. Basis of preparation

The financial statements have been prepared in accordance with FRS 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland including Section 1A Small Entities.

The financial statements have been prepared under the historical cost convention in accordance with the Companies Act 2006.

2.2. Turnover

Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and from the rendering of services.


Revenue from the sale of goods is recognised when the company has transferred to the buyer the significant risks and rewards of ownership of the goods, usually when goods are delivered and legal title has passed. Providing the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the company and the costs incurred or to be incurred in respect of the transition can be measured reliably.


Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.

2.3. Operating leases

Where, substantially, all the risks and rewards of ownership of the asset do not transfer from the lessor to the company, the lease is treated as an operating lease. Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

2.4. Foreign currencies

Foreign currency transactions are translated into the functional currency using the spot exchange rates at the dates of the transactions. At each period end foreign currency monetary items are translated using the closing rate. Non-monetary items measured at historical cost are translated using the exchange rate at the date of the transaction and non-monetary items measured at fair value are measured using the exchange rate when fair value was determined.

2.5. Current taxation

Current tax is recognised in profit or loss, except for taxes related to revaluations of land and buildings which are recognised in other comprehensive income.


Current tax represents the amount of tax payable (receivable) in respect of taxable profit (loss) for the current, or past, reporting periods. Current tax is measured at the amount expected to be paid (recovered) using the tax rates and laws which have been enacted, or substantively enacted, by the balance sheet date. Where payments to HM Revenue and Customs exceed liabilities owed, an asset is recognised to the extent of the amount of tax recoverable.

2.6. Deferred tax

Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.

2.7. Tangible fixed assets and depreciation

All fixed assets are initially recorded at cost. Property, plant and equipment is used in the company's principal activity for the production and supply of goods or for administrative purposes and is stated in the balance sheet under the historic cost model. This model requires the assets to be stated at cost less amounts in respect of depreciation and less any accumulated impairment losses. Depreciation is calculated so as to write off the cost of an asset, less its estimated residual value (which is the expected amount that would currently be obtained from disposal of an asset, after deducting the estimated costs of disposal, if the asset were already of the age and in the condition expected at the end of its useful life), over the useful economic life of the respective asset as follows:

Rate
Method
%
Plant and machinery
33.33
Straight-line

2.8. Investments

Investments in subsidiaries, associates, and joint ventures are measured at cost less any accumulated impairment losses. Other investments in equity instruments that are publicly traded are measured at fair value, with changes in fair value recognised in the income statement. Other investments in equity instruments that are not publicly traded are measured at fair value unless this cannot be measured reliably, in which case they are measured at cost less any accumulated impairment losses.

3. Employees

The average number of employees during the year was 1 (2025: 1).

4. Tangible fixed assets

Total
£
Cost
At 1 February 2025
38,296
Additions
4,596
At 31 January 2026
42,892
Depreciation and impairment
At 1 February 2025
29,769
Charge for the period
5,669
Other charges
1
At 31 January 2026
35,439
Net book value
At 31 January 2026
7,453
At 31 January 2025
8,527

5. Debtors

2026
2025
£
£
Trade debtors
45,043
12,100
Other debtors
65,269
56,407
Directors loan accounts
192,026
162,219
Total due within one year
302,338
230,726
Total due after one year
-
-
Total
302,338
230,726

6. Current asset investments

2026
2025
£
£
Other investments
555,315
509,481
Total
555,315
509,481

7. Creditors due within one year

2026
2025
£
£
Taxation and social security
54,986
69,101
Accruals and deferred income
3,024
2,475
Total
58,010
71,576

8. Directors advances, credits and guarantees

Director
Brought forward
Amounts advanced
Carried forward
£
£
£
Mr B Sparkes
162,219
29,807
192,026
Total
162,219
29,807
192,026

The above loan is unsecured and repayable on demand.

9. Provisions for liabilities

2026
2025
£
£
Deferred tax
1,821
2,131
Total
1,821
2,131

10. Share capital

2026
2025
£
£
Allotted, called up and fully paid
1 Ordinary £1 share
1
1
Total
1
1